SPECTROBID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Spectrobid, and when can generic versions of Spectrobid launch?
Spectrobid is a drug marketed by Pfizer and is included in two NDAs.
The generic ingredient in SPECTROBID is bacampicillin hydrochloride. There are two drug master file entries for this compound. Additional details are available on the bacampicillin hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SPECTROBID?
- What are the global sales for SPECTROBID?
- What is Average Wholesale Price for SPECTROBID?
Summary for SPECTROBID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 39 |
| Patent Applications: | 817 |
| DailyMed Link: | SPECTROBID at DailyMed |
US Patents and Regulatory Information for SPECTROBID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | SPECTROBID | bacampicillin hydrochloride | FOR SUSPENSION;ORAL | 050556-001 | Mar 23, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | SPECTROBID | bacampicillin hydrochloride | TABLET;ORAL | 050520-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | SPECTROBID | bacampicillin hydrochloride | TABLET;ORAL | 050520-002 | Sep 12, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
